Asian Eye’s Dr. Robert Ang has conducted important research on the ICLASIAN Eye Institute recently partnered with US-based STAAR Surgical Company, a leading developer, manufacturer and marketer of implantable contact lenses (ICLs), to offer EVO Visian ICL.
EVO Visian ICL is a solution for those who suffer from nearsightedness, farsightedness and/or astigmatism and no longer want to wear eyeglasses or contact lenses. It is a treatment alternative for patients who are not qualified for other LASIK surgeries like SMILE (small incision lenticule extraction) and PRK (photorefractive keratectomy).
Like regular contacts
“The implantable contact lenses function much like regular contact lenses,” Asian Eye cornea and refractive service director Dr. Robert Ang explained. “The only difference is that implantable contact lenses are inserted between the iris and the natural lens of the eye. It can stay inside the eye for the next 20 to 30 years, and it does not need to be removed cleaned or maintained regualrly.
“Having high nearsightedness or astigmatism, thin or irregular corneas and chronic dry eyes are no longer a hindrance to giving patients good vision. They can just come to the clinic for a screening for an overall evaluation of their eye condition,” Ang said.
“A lot of patients are beyond amazed after their procedure,” he added. “They now have clearer, sharper vision and better color perception. It’s truly remarkable that the implantable contact lenses can deliver such outstanding results very consistently. Not many products can make a doctor feel this way. It makes me happy to know that I am able to help improve their quality of life.
“Now they don’t need to worry about wearing glasses when they wake up in the morning just to check the time or constantly thinking about bringing their contact lens fluid and cases to disinfect lenses when they work or travel!”
Caren Mason, president and CEO of STAAR Surgical, shared how ICLs could help Filipinos.
She said: “Asian countries such as the Philippines are among the hardest hit by the explosive growth in nearsightedness and, in particular, progressive high nearsightedness that can lead to more serious eye diseases such as glaucoma and retinal detachment.
“We are thrilled to expand our partnership with Asian Eye. Both the eye institute and Dr. Ang are renowned for their high level of patient care and extensive research within the field of ophthalmology. Dr. Ang was recognized by ‘The Ophthalmologist’ on the 2018 Power List 100, which features top innovators in the field of ophthalmology. He has also conducted important research relating to the ICL, having presented his work at STAAR’s annual Experts Meetings during the European Society of Cataract and Refractive Surgery Congress. Asian Eye and Dr. Ang have demonstrated their commitment to vision care excellence and delighting patients for almost two decades.”